Company / Cost of Revenue
Apyx Medical Corp Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$19.8M
FY2025
5-year range
$10.2M / $19.8M
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $15M to $20M over the past 2 years.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +16.7%.
Increased from $15M to $20M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +16.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +16.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 5.6% year-over-year.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.8M | +5.6% |
| FY2024 | $18.7M | +21.9% |
| FY2023 | $15.4M | +0.0% |
| FY2022 | $15.4M | +50.7% |
| FY2021 | $10.2M | +11.7% |
| FY2020 | $9.1M | +179.0% |
| FY2019 | $3.3M | -11.5% |
| FY2018 | $3.7M | -78.2% |
| FY2017 | $17.0M | -9.2% |
| FY2016 | $18.7M | +29.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026